Remote Management of Device Aided Therapies in Patients with Movement Disorders

MDS OnDemand Series

 

Available now

This accredited webinar is provided free of cost to all members and non-members.
 

Register

Presented by

Alfonso Fasano, MD, PhD
Maurizio Zibetti, MD, PhD
Regina Katzenschlager, MD
Francesca Morgante, MD, PhD

Course Description

Device aided therapies (Deep Brain Stimulation and infusion therapies) are extensively used worldwide to treat patients with severe symptoms due to Parkinson’s Disease, Dystonia, Essential Tremor and Epilepsy. Development of Telemedicine platforms and possibility of delivering remote programming make these treatments suitable for remote management of clinical effects and troubleshooting. A recent study published in Movement Disorders Journal by Dr. Fasano’s group (Jitkritsadakul et al, Tele-health for patients with deep brain stimulation: The experience of the Ontario Telemedicine Network. Mov Disord, 2018) addresses this topic related to Deep Brain Stimulation. The recent COVID-19 pandemic highlighted the need to deliver structured Telemedicine Programs which could be carried on after the end of the pandemic to assist patients: 1) who needs to travel for long distances to reach the hospital; 2) who are unable to come to the hospital due to disease progression; 3) who experience sudden lack of benefit of those therapies and need to have immediate assistance.

This webinar would address on how to:

1) Program remote management of DBS device, using the patient’s remote control

2) Assess and manage patients with Infusion Therapies using a telemedicine platform

3) Deal with DBS and infusion therapies troubleshooting remotely

Target Audience
  • Movement Disorders Neurologists and Specialist Nurses who deals with device aided therapies
  • Young Movement Disorders members who wants to be trained on how to manage device aided therapies
  • General Movement Disorders Neurologists interested in learning about device aided therapies
     
Learning Objectives
  1. Assess remotely a patient with Tremor, Dystonia, Parkinson’s disease who carries a DBS device
  2. Assess remotely an advanced Parkinson’s disease patient who carries an infusion therapy
  3. Demonstrate programing remotely a DBS device
  4. Demonstrate managing remotely an infusion therapy system
  5. Explain remote DBS and infusion therapy troubleshooting
Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation.

Satisfactory Completion

Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.

Content Validity Statement

All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.

Faculty Financial Disclosure Information

All individuals in control of content for this webinar are required to disclose all relevant financial relationships with commercial interests as defined by the ACCME. Disclosure information is available here.

Top

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice